TAK1 activates PANoptosis through the NF-κB signalling pathway to delay diabetic wound healing

Abstract

Background: PANoptosis is a comprehensive form of cell death regulation that involves the interplay of pyroptosis, apoptosis, and necrosis. As a key regulator of PANoptosis, TAK1 plays a crucial role in multiple cell death pathways. However, its specific mechanism in the process of diabetic wound (DW) healing remains unclear. This study aimed to explore the role of TAK1 in regulating PANoptosis and its impact on DW healing. Methods: We used immunofluorescence, TUNEL staining, and EthD-III staining to analyse the relationship between TAK1 activity and PANoptosis. RNA sequencing was used to investigate the regulatory role of TAK1 and the NF-κB pathway under high-glucose conditions. Additionally, molecular docking and coimmunoprecipitation experiments were performed to verify the interaction between TAK1 and p65. Finally, a mouse model was used to study the effects of TAK1 knockdown on wound healing. Results: Our findings revealed that PANoptosis is significantly present in DW, with markedly upregulated TAK1 expression under high-glucose conditions. The inhibition of TAK1 expression significantly reduced cell death and promoted cell proliferation and migration. Mechanistically, TAK1 interacts with p65 through the NF-κB pathway, activating downstream signals that exacerbate cell damage in a high-glucose environment. TAK1 knockdown significantly suppressed PANoptosis, promoted microvascular and collagen formation, reduced inflammation, and further accelerated wound healing. Conclusion: TAK1 regulates PANoptosis by activating the NF-κB signalling pathway, thereby playing a crucial role in DW healing. Inhibiting TAK1 may represent a potential strategy to improve wound healing, with significant potential for clinical application.

Keywords

TAK1 / NF-κB / PANoptosis / Diabetic wound / Inflammation

References

[1] N. C. D. Risk Factor Collaboration . Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387:1513-30.

[2] Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271-81. https://doi.org/10.1016/j.diabres.2018.02.023.

[3] Boulton AJ. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev. 2008; 24:S3-6. https://doi.org/10.1002/dmrr.833.

[4] Li C, Xiong Y, Fu Z, et al. The direct binding of bioactive peptide Andersonin-W1 to TLR4 expedites the healing of diabetic skin wounds. Cell Mol Biol Lett. 2024; 29:24.

[5] Sun D, Guo K, Liu N, Li Y, Li Y, Hu Y, et al. Peptide RL-QN15 promotes wound healing of diabetic foot ulcers through p38 mitogen-activated protein kinase and smad3/miR-4482-3p/vascular endothelial growth factor B axis. Burns Trauma. 2023; 11:tkad035. https://doi.org/10.1093/burnst/tkad035.

[6] Wang G, Wang Y, Yang Q, et al. Metformin prevents methylglyoxal-induced apoptosis by suppressing oxidative stress in vitro and in vivo. Cell Death Dis. 2022; 13:29.

[7] Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019; 29:347-64. https://doi.org/10.1038/s41422-019-0164-5.

[8] Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022; 375:1254-61. https://doi.org/10.1126/science.abf0529.

[9] Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009; 137:1112-23. https://doi.org/10.1016/j.cell.2009.05.037.

[10] Vandenabeele P, Galluzzi L, Vanden Berghe T, et al. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010; 11:700-14. https://doi.org/10.1038/nrm2970.

[11] Wang S, Zhang Y, Wang M, Zhai Z, Tan Y, Xu W, et al. Noncanonical feedback loop between "RIP3-MLKL" and "4EBP1-eIF4E" promotes neuronal necroptosis. MedComm. 2020; 6:e70107. https://doi.org/10.1002/mco2.70107.

[12] Wang Y, Kanneganti TD. From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J. 2021; 19:4641-57. https://doi.org/10.1016/j.csbj.2021.07.038.

[13] Yan WT, Zhao WJ, Hu XM, Ban XX, Ning WY, Wan H, et al. PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons. Neural Regen Res. 2023; 18:357-63. https://doi.org/10.4103/1673-5374.346545.

[14] Hu XM, Zheng S, Zhang Q, Wan X, Li J, Mao R, et al. PANoptosis signaling enables broad immune response in psoriasis: from pathogenesis to new therapeutic strategies. Comput Struct Biotechnol J. 2024; 23:64-76. https://doi.org/10.1016/j.csbj.2023.11.049.

[15] Wan H, Ban X, He Y, Yang Y, Hu X, Shang L, et al. Voltage-dependent anion channel 1 oligomerization regulates PANoptosis in retinal ischemia-reperfusion injury. Neural Regen Res. 2026; 21:1652-64. https://doi.org/10.4103/NRR.NRR-D-24-00674.

[16] Place DE, Kanneganti TD. The innate immune system and cell death in autoinflammatory and autoimmune disease. Curr Opin Immunol. 2020; 67:95-105. https://doi.org/10.1016/j.coi.2020.10.013.

[17] Malireddi RKS, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019; 9:406.

[18] Huang K, He Y, Wan H, et al. Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024. Front Immunol. 2024; 15:1437570.

[19] Huang K, Zhang Q, Wan H, Ban XX, Chen XY, Wan XX, et al. TAK1 at the crossroads of multiple regulated cell death pathways: from molecular mechanisms to human diseases. FEBS J. 2025; 292:3849-77. https://doi.org/10.1111/febs.70042.

[20] Guo Q, Jin Y, Chen X, et al. NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024; 9:53.

[21] Mao H, Zhao X, Sun SC. NF-κB in inflammation and cancer. Cell Mol Immunol. 2025; 22:811-39. https://doi.org/10.1038/s41423-025-01310-w.

[22] Yadav JP, Verma A, Pathak P, et al. Phytoconstituents as modulators of NF-κB signalling: investigating therapeutic potential for diabetic wound healing. Biomed Pharmacother. 2024; 177:117058.

[23] Gao J, Xiong A, Liu J, Li X, Wang J, Zhang L, et al. PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment. Cancer Gene Ther. 2024; 31:970-83. https://doi.org/10.1038/s41417-024-00765-9.

[24] Lam CR, Tan MJ, Tan SH, Tang MB, Cheung PC, Tan NS. TAK1 regulates SCF expression to modulate PKB α activity that protects keratinocytes from ROS-induced apoptosis. Cell Death Differ. 2011; 18:1120-9. https://doi.org/10.1038/cdd.2010.182.

[25] Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 1999; 398:252-6.

[26] Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991; 139:271-9.

[27] Riccardi C, Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc. 2006; 1:1458-61.

[28] Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995; 36:774-86.

[29] Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000; 45:528-37.

[30] Pan J, Han L, Guo J, Wang X, Liu D, Tian J, et al. AIM2 accelerates the atherosclerotic plaque progressions in ApoE−/− mice. Biochem Biophys Res Commun. 2018; 498:487-94. https://doi.org/10.1016/j.bbrc.2018.03.005.

[31] Sych K, Nold SP, Pfeilschifter J, Vutukuri R, Meisterknecht J, Wittig I, et al. Expression of PKM2 in wound keratinocytes is coupled to angiogenesis during skin repair in vivo and in HaCaT keratinocytes in vitro. J Mol Med (Berl). 2023; 101:151-69. https://doi.org/10.1007/s00109-022-02280-6.

[32] Belvedere R, Novizio N, Morello S, et al. The combination of mesoglycan and VEGF promotes skin wound repair by enhancing the activation of endothelial cells and fibroblasts and their crosstalk. Sci Rep. 2022; 12:11041.

[33] Jia Q, Fu Z, Li Y, Kang Z, Wu Y, Ru Z, et al. Hydrogel loaded with peptide-containing nanocomplexes: symphonic cooperation of photothermal antimicrobial nanoparticles and pro-healing peptides for the treatment of infected wounds. ACS Appl Mater Interfaces. 2024; 16:13422-38. https://doi.org/10.1021/acsami.3c16061.

[34] Chang M. Restructuring of the extracellular matrix in diabetic wounds and healing: a perspective. Pharmacol Res. 2016; 107:243-8. https://doi.org/10.1016/j.phrs.2016.03.008.

[35] Tan W, Long T, Wan Y, et al. Dual-drug loaded polysaccharide-based self-healing hydrogels with multifunctionality for promoting diabetic wound healing. Carbohydr Polym. 2023; 312:120824.

[36] Wei Z, Li X, Zhou J, Zhou Y, Xiao Z, Yang Q, et al. Inhibition of miRNA-365-2-5p targeting SIRT1 regulates functions of keratinocytes to enhance wound healing. FASEB J. 2025; 39:e70560. https://doi.org/10.1096/fj.202401124RRR.

[37] Veli O, Kaya O, Varanda AB, et al. RIPK1 is dispensable for cell death regulation in beta-cells during hyperglycemia. Mol Metab. 2024; 87:101988.

[38] Xie W, Hu W, Huang Z, Li M, Zhang H, Huang X, et al. Betulinic acid accelerates diabetic wound healing by modulating hyperglycemia-induced oxidative stress, inflammation and glucose intolerance. Burns Trauma. 2022; 10:tkac007. https://doi.org/10.1093/burnst/tkac007.

[39] Yang Q, Fang D, Chen J, Hu S, Chen N, Jiang J, et al. LncRNAs associated with oxidative stress in diabetic wound healing: regulatory mechanisms and application prospects. Theranostics. 2023; 13:3655-74. https://doi.org/10.7150/thno.85823.

[40] Zhao Y, Zhao Y, Xu B, et al. Microenvironmental dynamics of diabetic wounds and insights for hydrogel-based therapeutics. J Tissue Eng. 2024; 15:20417314241253290.

[41] Wang Y, Jing L, Lei X, et al. Umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice via macrophage pyroptosis inhibition. Stem Cell Res Ther. 2023; 14:257.

[42] Justynski O, Bridges K, Krause W, Forni MF, Phan QM, Sandoval-Schaefer T, et al. Apoptosis recognition receptors regulate skin tissue repair in mice. elife. 2023; 12:e86269. https://doi.org/10.7554/eLife.86269.

[43] Gao P, Cao M, Jiang X, Wang X, Zhang G, Tang X, et al. Cannabinoid receptor 2-centric molecular feedback loop drives necroptosis in diabetic heart injuries. Circulation. 2023; 147:158-74. https://doi.org/10.1161/CIRCULATIONAHA.122.059304.

[44] Sun Z, Ye J, Sun W, et al. Cooperation of TRADD-and RIPK1-dependent cell death pathways in maintaining intestinal homeostasis. Nat Commun. 2025; 16:1890.

[45] Zhu L, Lama S, Tu L, Dusting GJ, Wang JH, Liu GS. TAK1 signaling is a potential therapeutic target for pathological angiogenesis. Angiogenesis. 2021; 24:453-70. https://doi.org/10.1007/s10456-021-09787-5.

[46] Guo F, Hutchenreuther J, Carter DE, Leask A. TAK1 is required for dermal wound healing and homeostasis. J Invest Dermatol. 2013; 133:1646-54. https://doi.org/10.1038/jid.2013.28.

[47] Wang W, Pang C, Zhang J, et al. Takinib inhibits microglial M1 polarization and oxidative damage after subarachnoid hemorrhage by targeting TAK1-dependent NLRP3 inflammasome signaling pathway. Front Immunol. 2023; 14:1266315.

[48] Xu X, Qi X, Shao Y, Li Y, Fu X, Feng S, et al. High glucose induced-macrophage activation through TGF-β-activated kinase 1 signaling pathway. Inflamm Res. 2016; 65:655-64. https://doi.org/10.1007/s00011-016-0948-8.

[49] Guo Y, Min J, Chang B, et al. Exploring the role of TRAF6-TAK1 pathway in podocyte pyroptosis and its implications for primary membranous nephropathy therapy. Inflammation. 2025; 48:3050-65. https://doi.org/10.1007/s10753-025-02249-w.

[50] Malireddi RKS, Gurung P, Kesavardhana S, Samir P, Burton A, Mummareddy H, et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. 2020; 217:jem.20191644. https://doi.org/10.1084/jem.20191644.

[51] Orning P, Weng D, Starheim K, Ratner D, Best Z, Lee B, et al. Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science. 2018; 362:1064-9. https://doi.org/10.1126/science.aau2818.

[52] Zhang H, Han Y, Xiao W, et al. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1. Cell Death Dis. 2023; 14:730.

[53] Zhang Y, Zhang YY, Pan ZW, Li QQ, Sun LH, Li X, et al. GDF11 promotes wound healing in diabetic mice via stimulating HIF-1a-VEGF/SDF-1a-mediated endothelial progenitor cell mobilization and neovascularization. Acta Pharmacol Sin. 2023; 44:999-1013. https://doi.org/10.1038/s41401-022-01013-2.

[54] Guan H, Li J, Tan X, Luo S, Liu Y, Meng Y, et al. Natural xanthone α-mangostin inhibits LPS-induced microglial inflammatory responses and memory impairment by blocking the TAK1/NF-κB signaling pathway. Mol Nutr Food Res. 2020; 64:e2000096. https://doi.org/10.1002/mnfr.202000096.

[55] Chang M, Nguyen TT. Strategy for treatment of infected diabetic foot ulcers. Acc Chem Res. 2021; 54:1080-93. https://doi.org/10.1021/acs.accounts.0c00864.

[56] Peng X, He F, Mao Y, Lin Y, Fang J, Chen Y, et al. miR-146a promotes M2 macrophage polarization and accelerates diabetic wound healing by inhibiting the TLR4/NF-κB axis. J Mol Endocrinol. 2022; 69:315-27. https://doi.org/10.1530/JME-21-0019.

[57] Xu YR, Lei CQ. TAK1-TABs complex: a central signalosome in inflammatory responses. Front Immunol. 2020; 11:608976.

[58] Wang W, Xia T, Yu X. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro. Inflamm Res. 2015; 64:423-31. https://doi.org/10.1007/s00011-015-0822-0.

[59] Ridder DA, Wenzel J, Muller K, et al. Brain endothelial TAK1 and NEMO safeguard the neurovascular unit. J Exp Med. 2015; 212:1529-49. https://doi.org/10.1084/jem.20150165.

[60] Dulmovits BM, Herman IM. Microvascular remodeling and wound healing: a role for pericytes. Int J Biochem Cell Biol. 2012; 44:1800-12. https://doi.org/10.1016/j.biocel.2012.06.031.

[61] Okonkwo UA, Chen L, Ma D, Haywood VA, Barakat M, Urao N, et al. Compromised angiogenesis and vascular integrity in impaired diabetic wound healing. PLoS One. 2020; 15:e0231962. https://doi.org/10.1371/journal.pone.0231962.

[62] Tejedor S, Wagberg M, Correia C, et al. The combination of vascular endothelial growth factor A (VEGF-A) and fibroblast growth factor 1 (FGF1) modified mRNA improves wound healing in diabetic mice: an ex vivo and in vivo investigation. Cells. 2024; 13:414.